Weight-loss drugs like Ozempic could also help fight dementia but raise other health risks, study says

15 hours ago 1
Boxes of Ozempic and Mounjaro, semaglutide and tirzepatide injection drugs used for treating type 2 diabetes and made by Novo Nordisk and Lilly

Ozempic was first approved to treat diabetes in Canada seven years ago. Now the largest study of its kind suggests it and other medications like it have a host of other potential health benefits beyond obesity, but could also bring increased risk of other conditions.

Read Entire Article